inclusion criteria: 1. age of 18-65 years (inclusive) ,women or man 2. sars-cov-2 detected in the diagnostic specimen (nasopharyngeal swab) 3. high homology of viral gene sequencing with the known sars-cov-2." 4. mild/moderateillness covid-19 or sars-cov-2 asymptomatic infection 5. within 7 days from the onset time of symptoms to randomization or within 5 days from the first time of sars-cov-2 positive test to randomization with required viral load 6. no plan of pregnancy and being willing to use effective contraceptive measures 7. signed the informed consent form, sufficiently understanding of the content

inclusion criteria: 1. age of 18-65 years (inclusive) ,women or man 2. sars-cov-2 detected in the diagnostic specimen (nasopharyngeal swab) 3. high homology of viral gene sequencing with the known sars-cov-2." 4. mild/moderateillness covid-19 or sars-cov-2 asymptomatic infection 5. within 7 days from the onset time of symptoms to randomization or within 5 days from the first time of sars-cov-2 positive test to randomization with required viral load 6. no plan of pregnancy and being willing to use effective contraceptive measures 7. signed the informed consent form, sufficiently understanding of the content

inclusion criteria: age of 18-65 years (inclusive) ,women or man sars-cov-2 detected in the diagnostic specimen (nasopharyngeal swab) high homology of viral gene sequencing with the known sars-cov-2." mild/moderateillness covid-19 or sars-cov-2 asymptomatic infection within 7 days from the onset time of symptoms to randomization or within 5 days from the first time of sars-cov-2 positive test to randomization with required viral load no plan of pregnancy and being willing to use effective contraceptive measures signed the informed consent form, sufficiently understanding of the content

inclusion criteria: age of 18-65 years (inclusive) ,women or man sars-cov-2 detected in the diagnostic specimen (nasopharyngeal swab) high homology of viral gene sequencing with the known sars-cov-2." mild/moderateillness covid-19 or sars-cov-2 asymptomatic infection within 7 days from the onset time of symptoms to randomization or within 5 days from the first time of sars-cov-2 positive test to randomization with required viral load no plan of pregnancy and being willing to use effective contraceptive measures signed the informed consent form, sufficiently understanding of the content

inclusion criteria: 1. age of 18-65 years (inclusive) ,women or man 2. sars-cov-2 detected in the diagnostic specimen (nasopharyngeal swab) 3. high homology of viral gene sequencing with the known sars-cov-2." 4. mild/moderateillness covid-19 or sars-cov-2 asymptomatic infection 5. within 7 days from the onset time of symptoms to randomization or within 5 days from the first time of sars-cov-2 positive test to randomization with required viral load 6. no plan of pregnancy and being willing to use effective contraceptive measures 7. signed the informed consent form, sufficiently understanding of the content

inclusion criteria: 1. age of 18-65 years (inclusive) ,women or man 2. sars-cov-2 detected in the diagnostic specimen (nasopharyngeal swab) 3. high homology of viral gene sequencing with the known sars-cov-2." 4. mild/moderateillness covid-19 or sars-cov-2 asymptomatic infection 5. within 7 days from the onset time of symptoms to randomization or within 5 days from the first time of sars-cov-2 positive test to randomization with required viral load 6. no plan of pregnancy and being willing to use effective contraceptive measures 7. signed the informed consent form, sufficiently understanding of the content